Drugs Made In America Acquisition (DMII) Payables (2024 - 2025)
Drugs Made In America Acquisition (DMII) posted quarterly Payables of $99359.0 for Q4 2025, down 60.27% year-over-year from $250100.0 in Q4 2024, and up 2063.74% quarter-over-quarter from $4592.0 in Q3 2025.
Drugs Made In America Acquisition (DMII) Payables (2024 - 2025) Analysis & Trends
Drugs Made In America Acquisition (DMII) has reported Payables for 2 consecutive years, with $99359.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Payables fell 60.27% year-over-year to $99359.0; the TTM figure through Dec 2025 stood at $99359.0 (down 60.27% YoY), while the FY2025 annual figure was $99359.0, down 60.27% from the prior year.
- Payables advanced to $99359.0 in Q4 2025 per DMII's latest filing, from $4592.0 in the prior quarter.
- Across five years, Payables topped out at $250100.0 in Q4 2024 and bottomed at $4592.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | - |
| 2 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 462,253.00 |
| 3 | Cantor Equity Partners IV | 467.55 Mn | 467.55 Mn | - | 25,000.00 |
| 4 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 595,000.00 |
| 5 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 20,057.00 |
| 6 | Gores Holdings X | 381.05 Mn | 380.85 Mn | - | -1.52 Mn |
| 7 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 8.00 Mn |
| 8 | Blue Water Acquisition Corp. III | 342.12 Mn | 342.08 Mn | - | 568,514.00 |
| 9 | Berto Acquisition | 313.96 Mn | 313.81 Mn | - | 297,749.00 |
| 10 | New Providence Acquisition Corp. III | 313.81 Mn | 313.81 Mn | - | 1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 99,359.00 |
| Sep 30, 2025 | 4,592.00 |
| Dec 31, 2024 | 250,100.00 |